期刊文献+

人脑胶质瘤微血管数与病理级别及预后关系的初步研究 被引量:6

A study on relationship between microvessel quantity and histological grade and prognosis in glioma.
下载PDF
导出
摘要 目的探讨人脑胶质瘤微血管数(MVQ)与病理级别、术后复发、生存期及患者年龄、性别、肿瘤生长部位的关系。方法应用免疫组织化学ABC法检测63例人脑胶质瘤组织中Ⅷ因子相关抗原(FⅧRAg)的表达,计数MVQ。结果高恶性度(Ⅲ、Ⅳ级)胶质瘤MVQ高于低恶性度(Ⅰ、Ⅱ级)胶质瘤(P<0.05)。术后18个月内复发及生存期小于3年者MVQ均明显高于对应组(P均<0.01)。MVQ与患者性别、年龄及肿瘤生长部位无关。结论人脑胶质瘤MVQ与病理级别、术后复发及生存期关系密切。 Objective To research the relationship among microvessel quantity (MVQ), age, sex, tumor position, histological grade, postoperative recurrence and survival period in glioma.Methods Using ABC immunohistochemistry method, the expression of factor Ⅷ related antigen (FⅧRAg) and MVQ were observed in 63 cases of glioma.Results MVQ in high malignant (grade Ⅲ,Ⅳ) glioma was higher than that in low malignant (grade Ⅰ,Ⅱ) glioma ( P<0.05 ). MVQ in tumor tissues of the patients in whom tumors recurred in 18 postoperative months and survival periods were less than 3 years was significantly higher than that of counterparts ( P<0.01 ). MVQ was not correlated to patient age, sex and tumor location.Conclusions MVQ was obviously correlated to histological grade, postoperative recurrence and survial period in glioma, MVQ may be an independent prognostic indicator.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 1999年第3期153-155,共3页 Chinese Journal of Nervous and Mental Diseases
关键词 脑肿瘤 胶质瘤 微血管数 病理级别 预后 Glioma Microvessel quantity Factor Ⅷ related antigen Prognosis
  • 相关文献

同被引文献32

  • 1范恩学,孙海侠,丁道亮,王志民.血管抑素和内皮抑素在小鼠开窗肿瘤模型的应用[J].中华实验外科杂志,2004,21(7):872-872. 被引量:5
  • 2林志雄,陈锦峰,张鹏飞,吴翊钦,王玮.星形细胞瘤生物学行为特征及机理探讨[J].微侵袭神经外科杂志,1997,2(1):44-50. 被引量:12
  • 3王守森,王如小,张锡增,余英豪.多发性脑胶质瘤7例报告[J].中国神经精神疾病杂志,1995,21(2):100-101. 被引量:16
  • 4孙建军,王振宇.脑胶质瘤浸润性和抗血管增生治疗[J].中华神经医学杂志,2005,4(9):960-962. 被引量:4
  • 5Chen SY, Yang AG, Chen JD, et al Potent antitumour activity of a new class of tumour-specific killer cells [ J]. Nature, 1997, 385 (6611) : 78 -80.
  • 6Pastan I, Hassan R, Fitzgerald D J, et al Immunotoxin therapy of cancer [J]. Nat Rev Cancer, 2006, 6(7): 559-565.
  • 7Crittenden M, Gough M, Chester J, et al Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy [J]. Cancer Res, 2003,63 (12) : 3173 - 3180.
  • 8Jia J, Li H, Tai S, et al Construction and preliminary investigation of a plasmid containing a novel immunotoxin DT390-IL-18 gene for the prevention of murine experimental autoimmune encephalomyelitis [J]. DNA Cell Biol, 2008, 27(5) : 279 -285.
  • 9Kreitman RJ. Immunotoxins for targeted cancer therapy [ J ]. AAPS J, 2006, 8(3) : E532 -551.
  • 10Arora N, Masood R, Zheng T, et al Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells [ J]. Cancer Res, 1999, 59(1): 183-188.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部